Michiko Yamamoto

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 231 citations · Full text

Open-label Trial, Late Favipiravir Therapy, Clinical Infectious Disease +14

Relationship between health literacy, health information access, health behavior, and health status in Japanese people

Machi Suka, Takeshi Odajima, Masako Okamoto et al. · Patient Education and Counseling · 2015 · 202 citations

Health Policy, Health Data, Nutrition Literacy +12

Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia

Yasuyuki Katayama, Takuhiko Akatsu, Michiko Yamamoto et al. · Journal of Bone and Mineral Research · 1996 · 201 citations

Tissue Engineering, Engineering, Biomedical Engineering +17

Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like Cells

Takehiko Murakami, Michiko Yamamoto, Mikio Yamamoto et al. · Biochemical and Biophysical Research Communications · 1998 · 195 citations

Murine Osteoclast-like Cells, Developmental Biology, Bone Morphogenic Protein +8

Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures

Masanobu Nishikawa, Takuhiko Akatsu, Yasuyuki Katayama et al. · Bone · 1996 · 162 citations

Bone Morphogenic Protein, Mouse Marrow Cultures, Bone Metabolism +6